LGM

Logos Global Management Portfolio holdings

AUM $1.5B
1-Year Est. Return 197.64%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+197.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$899M
AUM Growth
+$198M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
71
New
Increased
Reduced
Closed

Top Buys

1
+$67.6M
2
+$32.7M
3
+$22.6M
4
VTYX icon
Ventyx Biosciences
VTYX
+$16.9M
5
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$14.1M

Top Sells

1
+$23.7M
2
+$19.2M
3
+$16.9M
4
RCKT icon
Rocket Pharmaceuticals
RCKT
+$15.4M
5
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$15.3M

Sector Composition

1 Healthcare 100%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$136M 15.09%
1,625,000
+375,000
2
$64M 7.12%
1,800,000
-450,000
3
$56.9M 6.32%
950,000
+200,000
4
$55.2M 6.13%
+145,000
5
$54.4M 6.05%
4,383,875
+640,000
6
$50.6M 5.62%
1,200,000
-400,000
7
$43.6M 4.85%
1,070,058
+570,058
8
$38.2M 4.25%
1,275,000
-700,000
9
$35.3M 3.93%
+568,173
10
$29.9M 3.33%
2,100,000
+1,985,000
11
$28.5M 3.17%
90,000
-25,000
12
$27.3M 3.04%
400,000
-50,000
13
$25M 2.78%
1,880,000
-300,000
14
$22.5M 2.5%
4,950,000
-350,000
15
$18.7M 2.08%
800,000
+200,000
16
$17.8M 1.98%
+4,000,000
17
$14.6M 1.62%
1,475,000
+525,000
18
$13.3M 1.48%
5,032,501
19
$13.1M 1.45%
600,000
-450,000
20
$10.4M 1.16%
+950,000
21
$10M 1.12%
350,000
+100,000
22
$9.32M 1.04%
+1,250,000
23
$9.06M 1.01%
+150,000
24
$8.25M 0.92%
+5,850,000
25
$8.1M 0.9%
+1,200,000
1
2 3